S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in
NASDAQ:SAGE

Sage Therapeutics News Headlines

$85.00
+1.55 (+1.86 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$80.47
Now: $85.00
$85.15
50-Day Range
$78.47
MA: $85.62
$96.76
52-Week Range
$25.01
Now: $85.00
$98.39
Volume1.07 million shs
Average Volume502,165 shs
Market Capitalization$4.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.23

Headlines

Sage Therapeutics (NASDAQ SAGE) News Headlines Today

Source:
SourceHeadline
Mizuho Downgrades Sage Therapeutics (NASDAQ:SAGE) to NeutralMizuho Downgrades Sage Therapeutics (NASDAQ:SAGE) to Neutral
marketbeat.com - February 26 at 7:08 AM
Sage Therapeutics, Inc. (NASDAQ:SAGE) Forecasted to Post FY2022 Earnings of ($7.10) Per ShareSage Therapeutics, Inc. (NASDAQ:SAGE) Forecasted to Post FY2022 Earnings of ($7.10) Per Share
americanbankingnews.com - February 26 at 11:46 AM
Sage Therapeutics, Inc. (NASDAQ:SAGE) Analysts Just Cut Their EPS Forecasts SubstantiallySage Therapeutics, Inc. (NASDAQ:SAGE) Analysts Just Cut Their EPS Forecasts Substantially
finance.yahoo.com - February 26 at 10:15 AM
Mizuho Lowers Sage Therapeutics (NASDAQ:SAGE) to NeutralMizuho Lowers Sage Therapeutics (NASDAQ:SAGE) to Neutral
americanbankingnews.com - February 26 at 8:02 AM
Sage Therapeutics EPS of $18.19Sage Therapeutics EPS of $18.19
seekingalpha.com - February 25 at 11:46 PM
Sage Therapeutics (NASDAQ:SAGE) Posts Quarterly  Earnings Results, Beats Expectations By $20.36 EPSSage Therapeutics (NASDAQ:SAGE) Posts Quarterly Earnings Results, Beats Expectations By $20.36 EPS
americanbankingnews.com - February 25 at 2:36 PM
Sage Therapeutics (NASDAQ:SAGE) PT Raised to $102.00 at OppenheimerSage Therapeutics (NASDAQ:SAGE) PT Raised to $102.00 at Oppenheimer
americanbankingnews.com - February 25 at 12:47 PM
Sage Therapeutics (NASDAQ:SAGE) Rating Reiterated by HC WainwrightSage Therapeutics (NASDAQ:SAGE) Rating Reiterated by HC Wainwright
americanbankingnews.com - February 25 at 9:33 AM
HC Wainwright Raises Sage Therapeutics (NASDAQ:SAGE) Price Target to $86.00HC Wainwright Raises Sage Therapeutics (NASDAQ:SAGE) Price Target to $86.00
americanbankingnews.com - February 25 at 9:33 AM
Sage Posts Surprise Quarterly Profit As Sales Surge; Shares Pop 6%Sage Posts Surprise Quarterly Profit As Sales Surge; Shares Pop 6%
finance.yahoo.com - February 25 at 8:44 AM
Sage Therapeutics (NASDAQ:SAGE) Trading Up 6%Sage Therapeutics (NASDAQ:SAGE) Trading Up 6%
americanbankingnews.com - February 24 at 9:38 PM
Recap: Sage Therapeutics Q4 EarningsRecap: Sage Therapeutics Q4 Earnings
benzinga.com - February 24 at 12:43 PM
Sage Therapeutics Rises After Swing to Profit on Biogen DealSage Therapeutics Rises After Swing to Profit on Biogen Deal
finance.yahoo.com - February 24 at 12:43 PM
Sage Therapeutics, Inc. 2020 Q4 - Results - Earnings Call PresentationSage Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 24 at 8:42 AM
Sage Therapeutics (NASDAQ:SAGE) & Vanda Pharmaceuticals (NASDAQ:VNDA) Head to Head AnalysisSage Therapeutics (NASDAQ:SAGE) & Vanda Pharmaceuticals (NASDAQ:VNDA) Head to Head Analysis
americanbankingnews.com - February 19 at 6:24 AM
Sage Therapeutics, Inc. (SAGE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseSage Therapeutics, Inc. (SAGE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
msn.com - February 17 at 5:52 PM
Sage Therapeutics (SAGE) Set to Announce Earnings on WednesdaySage Therapeutics (SAGE) Set to Announce Earnings on Wednesday
americanbankingnews.com - February 17 at 3:36 AM
Sage Therapeutics to Present at Upcoming Investor ConferencesSage Therapeutics to Present at Upcoming Investor Conferences
finance.yahoo.com - February 11 at 6:09 PM
Sage Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021Sage Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
finance.yahoo.com - February 10 at 8:12 AM
Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare ConferenceSage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 8:40 AM
Sage Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021Sage Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021
finance.yahoo.com - December 23 at 8:10 AM
Is SAGE A Good Stock To Buy According To Hedge Funds?Is SAGE A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 22 at 12:57 PM
Industry Analysts Just Upgraded Their Sage Therapeutics, Inc. (NASDAQ:SAGE) Revenue Forecasts By 23%Industry Analysts Just Upgraded Their Sage Therapeutics, Inc. (NASDAQ:SAGE) Revenue Forecasts By 23%
finance.yahoo.com - December 20 at 2:34 PM
Should You Buy Sage Stock After the Biogen Investment?Should You Buy Sage Stock After the Biogen Investment?
finance.yahoo.com - December 19 at 8:06 AM
Interesting SAGE Put And Call Options For August 2021Interesting SAGE Put And Call Options For August 2021
nasdaq.com - December 18 at 1:32 PM
Top former Alnylam exec Barry Greene named CEO of Sage TherapeuticsTop former Alnylam exec Barry Greene named CEO of Sage Therapeutics
bizjournals.com - December 16 at 5:46 PM
First Week of May 2021 Options Trading For Sage TherapeuticsFirst Week of May 2021 Options Trading For Sage Therapeutics
nasdaq.com - December 3 at 5:07 PM
Sage Therapeutics to Present at BMO 2020 Growth & ESG ConferenceSage Therapeutics to Present at BMO 2020 Growth & ESG Conference
finance.yahoo.com - December 3 at 5:07 PM
Party Time: Brokers Just Made Major Increases To Their Sage Therapeutics, Inc. (NASDAQ:SAGE) Earnings ForecastsParty Time: Brokers Just Made Major Increases To Their Sage Therapeutics, Inc. (NASDAQ:SAGE) Earnings Forecasts
nasdaq.com - December 2 at 8:08 AM
This Just In: Analysts Are Boosting Their Sage Therapeutics, Inc. (NASDAQ:SAGE) Outlook for Next YearThis Just In: Analysts Are Boosting Their Sage Therapeutics, Inc. (NASDAQ:SAGE) Outlook for Next Year
finance.yahoo.com - December 2 at 8:07 AM
Biogen Inc. (BIIB) CEO Michel Vounatsos Presents at Biogen and Sage Collaboration Conference Call (Transcript)Biogen Inc. (BIIB) CEO Michel Vounatsos Presents at Biogen and Sage Collaboration Conference Call (Transcript)
seekingalpha.com - November 30 at 5:03 PM
Sage Therapeutics Inks $1.5 Billion Development Deal with Biogen; Mizuho Stays SidelinedSage Therapeutics Inks $1.5 Billion Development Deal with Biogen; Mizuho Stays Sidelined
finance.yahoo.com - November 29 at 4:57 PM
Biogen teams up with Sage Therapeutics (SAGE) to develop therapies in depressionBiogen teams up with Sage Therapeutics (SAGE) to develop therapies in depression
seekingalpha.com - November 27 at 10:05 PM
Biogen, Sage Therapeutics enter $1.5 billion deal to develop, sell depression drugBiogen, Sage Therapeutics enter $1.5 billion deal to develop, sell depression drug
msn.com - November 27 at 5:05 PM
Biogen, Sage Therapeutics To Jointly Develop And Commercialize Zuranolone, SAGE-324Biogen, Sage Therapeutics To Jointly Develop And Commercialize Zuranolone, SAGE-324
nasdaq.com - November 27 at 5:05 PM
Biogen, Sage Therapeutics enter $1.5 billion deal to develop, sell neurological treatmentsBiogen, Sage Therapeutics enter $1.5 billion deal to develop, sell neurological treatments
msn.com - November 27 at 5:05 PM
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies inBiogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in
bloomberg.com - November 27 at 7:52 AM
Biogen Inc.; Sage Therapeutics: Biogen and Sage Therapeutics Announce Global Collaboration to Develop and CommercializeBiogen Inc.; Sage Therapeutics: Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize
bloomberg.com - November 27 at 7:52 AM
Biogen teams up with Sage Therapeutics to develop therapies in depressionBiogen teams up with Sage Therapeutics to develop therapies in depression
seekingalpha.com - November 27 at 7:52 AM
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement DisordersBiogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
finance.yahoo.com - November 27 at 7:51 AM
Sage Therapeutics to receive $1.525 billion in cash in deal with Biogen to jointly develop depression, tremor therapiesSage Therapeutics to receive $1.525 billion in cash in deal with Biogen to jointly develop depression, tremor therapies
finance.yahoo.com - November 27 at 7:51 AM
Positive catalysts for Sage Therapeutics called out by OppenheimerPositive catalysts for Sage Therapeutics called out by Oppenheimer
seekingalpha.com - November 19 at 8:49 AM
Some Analysts Just Cut Their Sage Therapeutics, Inc. (NASDAQ:SAGE) EstimatesSome Analysts Just Cut Their Sage Therapeutics, Inc. (NASDAQ:SAGE) Estimates
finance.yahoo.com - November 18 at 9:19 AM
Interesting SAGE Put And Call Options For December 31stInteresting SAGE Put And Call Options For December 31st
nasdaq.com - November 12 at 1:55 PM
Sage Therapeutics, Inc. (NASDAQ:SAGE) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportSage Therapeutics, Inc. (NASDAQ:SAGE) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
finance.yahoo.com - November 9 at 9:37 AM
Sage Therapeutics Inc (SAGE) Q3 2020 Earnings Call TranscriptSage Therapeutics Inc (SAGE) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 5 at 11:17 PM
Sage Therapeutics (SAGE) Management on Q3 2020 Results - Earnings Call TranscriptSage Therapeutics' (SAGE) Management on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 6:16 PM
Sage Therapeutics: Q3 Earnings InsightsSage Therapeutics: Q3 Earnings Insights
finance.yahoo.com - November 5 at 1:16 PM
Sage Therapeutics EPS beats by $0.34, misses on revenueSage Therapeutics EPS beats by $0.34, misses on revenue
seekingalpha.com - November 5 at 8:15 AM
Sage Therapeutics Q3 Earnings PreviewSage Therapeutics Q3 Earnings Preview
seekingalpha.com - November 4 at 2:25 PM
Sage Therapeutics to Present at Upcoming November Investor ConferencesSage Therapeutics to Present at Upcoming November Investor Conferences
finance.yahoo.com - November 2 at 7:57 AM
This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.